Ito T, Kagoshima M, Sasaki Y, Li C, Udaka N, Kitsukawa T, Fujisawa H, Taniguchi M, Yagi T, Kitamura H, Goshima Y
Department of Pathology, Yokohama City University School of Medicine, 3-9 Fuku-Ura, Kanazawa-ku, 236-0004, Yokohama, Japan.
Mech Dev. 2000 Oct;97(1-2):35-45. doi: 10.1016/s0925-4773(00)00401-9.
Semaphorin III/collapsin-1 (Sema3A) guides a specific subset of neuronal growth cones as a repulsive molecule. In this study, we have investigated a possible role of non-neuronal Sema3A in lung morphogenesis. Expression of mRNAs of Sema3A and neuropilin-1 (NP-1), a Sema3A receptor, was detected in fetal and adult lungs. Sema3A-immunoreactive cells were found in airway and alveolar epithelial cells of the fetal and adult lungs. Immunoreactivity for NP-1 was seen in fetal and adult alveolar epithelial cells as well as endothelial cells. Immunoreactivity of collapsin response mediator protein CRMP (CRMP-2), an intracellular protein mediating Sema3A signaling, was localized in alveolar epithelial cells, nerve tissue and airway neuroendocrine cells. The expression of CRMP-2 increased during the fetal, neonate and adult periods, and this pattern paralleled that of NP-1. In a two-day culture of lung explants from fetal mouse lung (E11.5), with exogenous Sema3A at a dose comparable to that which induces growth cone collapse of dorsal root ganglia neurons, the number of terminal buds was reduced in a dose-dependent manner when compared with control or untreated lung explants. This decrease was not accompanied with any alteration of the bromodeoxyuridine-positive DNA-synthesizing fraction. A soluble NP-1 lacking the transmembrane and intracellular region, neutralized the inhibitory effect of Sema3A. The fetal lung explants from neuropilin-1 homozygous null mice grew normally in vitro regardless of Sema3A treatment. These results provide evidence that Sema3A inhibits branching morphogenesis in lung bud organ cultures via NP-1 as a receptor or a component of a possible multimeric Sema3A receptor complex.
信号素III/塌陷素-1(Sema3A)作为一种排斥分子引导特定子集的神经元生长锥。在本研究中,我们调查了非神经元Sema3A在肺形态发生中的可能作用。在胎儿和成人肺中检测到Sema3A和其受体神经纤毛蛋白-1(NP-1)的mRNA表达。在胎儿和成人肺的气道和肺泡上皮细胞中发现了Sema3A免疫反应性细胞。在胎儿和成人肺泡上皮细胞以及内皮细胞中可见NP-1的免疫反应性。作为介导Sema3A信号传导的细胞内蛋白,塌陷反应介导蛋白CRMP(CRMP-2)的免疫反应性定位于肺泡上皮细胞、神经组织和气道神经内分泌细胞。CRMP-2的表达在胎儿期、新生儿期和成年期增加,且这种模式与NP-1的模式平行。在来自胎儿小鼠肺(E11.5)的肺外植体的两天培养中,使用与诱导背根神经节神经元生长锥塌陷剂量相当的外源性Sema3A,与对照或未处理的肺外植体相比,终末芽的数量以剂量依赖性方式减少。这种减少并未伴随着溴脱氧尿苷阳性DNA合成部分的任何改变。一种缺乏跨膜和细胞内区域的可溶性NP-1中和了Sema3A的抑制作用。来自神经纤毛蛋白-1纯合缺失小鼠的胎儿肺外植体在体外无论是否用Sema3A处理均正常生长。这些结果提供了证据表明Sema3A通过NP-1作为受体或可能的多聚体Sema3A受体复合物的一个组分抑制肺芽器官培养中的分支形态发生。